Evidence map›Paper›PMID 39369012›Full record

ArticleScientific reports2024

Combining human liver ECM with topographically featured electrospun scaffolds for engineering hepatic microenvironment.

Yunxi Gao, Victoria L Gadd, Maria Heim, Rhiannon Grant, Thomas S R Bate, Hannah Esser, Sofia Ferreira Gonzalez, Tak Yung Man, Stuart J Forbes, Anthony Callanan

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A Systematic Review on Artificial Liver for Implantation.Journal of functional biomaterials · 2026
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yunxi GaoInstitute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-6793-3954
Victoria L GaddCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0003-1819-8660
Maria HeimInstitute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-9651-4414
Rhiannon GrantMERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0003-1507-2042
Thomas S R BateInstitute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-1517-9520
Hannah EsserInstitute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-3980-7381
Sofia Ferreira GonzalezCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-7776-287X
Tak Yung ManCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
Stuart J ForbesCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-3715-2561
Anthony CallananInstitute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK. Anthony.Callanan@ed.ac.uk.ORCID http://orcid.org/0000-0002-1871-2853

Funding

MRC CCBN Grant MR/L012766/1UKRMPII Grant MR/L022974/1
6 · The paper itself

Abstract

Liver disease cases are rapidly expanding worldwide, and transplantation remains the only effective cure for end-stage disease. There is an increasing demand for developing potential drug treatments, and regenerative therapies using in-vitro culture platforms. Human decellularized extracellular matrix (dECM) is an appealing alternative to conventional animal tissues as it contains human-specific proteins and can serve as scaffolding materials. Herein we exploit this with human donor tissue from discarded liver which was not suitable for transplant using a synergistic approach to combining biological and topographical cues in electrospun materials as an in-vitro culture platform. To realise this, we developed a methodology for incorporating human liver dECM into electrospun polycaprolactone (PCL) fibres with surface nanotopographies (230-580 nm). The hybrid scaffolds were fabricated using varying concentrations of dECM; their morphology, mechanical properties, hydrophilicity and stability were analysed. The scaffolds were validated using HepG2 and primary mouse hepatocytes, with subsequent results indicating that the modified scaffolds-maintained cell growth and influenced cell attachment, proliferation and hepatic-related gene expression. This work demonstrates a novel approach to harvesting the potential from decellularized human tissues in the form of innovative in-vitro culture platforms for liver.

Indexed as

HepatocytesLiverTissue EngineeringTissue ScaffoldsAnimalsCell AdhesionCell ProliferationCellular MicroenvironmentDecellularized Extracellular MatrixExtracellular MatrixHep G2 CellsHumansMicePolyestersDecellularized Extracellular MatrixpolycaprolactonePolyestersCell scaffoldDecellularizationElectrospinningHuman extracellular matrixLiver tissue engineeringTopography

Identifiers

PMID39369012
PMCPMC11455933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.